Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...

A recent study linking human pegivirus to Parkinson’s is leading scientists to examine the connection between other viral ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...

The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...

Bec Judd makes startling health confession as she aims to be 'completely transparent' on her Vain-ish podcast Rebecca Judd ...

A mouse study showed a link between an infection with herpes simplex virus type 1 (HSV-1), the cause of cold sores, and MS.

Alzheimer's disease, affecting millions, is projected to surge by 2050. Research suggests a potential link between herpes ...

SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...

A deft uveitis diagnosis can help reveal underlying systemic infections, neoplastic conditions, and other systemic illnesses.

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...